{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:05:31Z","timestamp":1770239131277,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ygyno.2013.06.031","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T17:30:39Z","timestamp":1372527039000},"page":"69-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer"],"prefix":"10.1016","volume":"131","author":[{"given":"Suiyang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangdan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiemin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Wing","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross S.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ygyno.2013.06.031_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.031_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","article-title":"Focus on epithelial ovarian cancer","volume":"5","author":"Ozols","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.031_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejca.2009.10.003","article-title":"Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancer","volume":"46","author":"Tang","year":"2010","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.031_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bpobgyn.2011.11.006","article-title":"Screening for ovarian cancer in the general population","volume":"26","author":"Gentry-Maharaj","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"11","key":"10.1016\/j.ygyno.2013.06.031_bb0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan David","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.031_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2012.08.016","article-title":"The PI3K\/Akt\/mTOR signaling pathway mediates insulin-like growth factor 1 induced E-cadherin down-regulation and cell proliferation in ovarian cancer cell","volume":"326","author":"Lau","year":"2012","journal-title":"Cancer Lett"},{"issue":"36","key":"10.1016\/j.ygyno.2013.06.031_bb0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.2012.43.5933","volume":"30","author":"Guerra","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.06.031_bb0040","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s13277-011-0204-3","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"Tumour Biol"},{"issue":"12","key":"10.1016\/j.ygyno.2013.06.031_bb0045","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1158\/1541-7786.MCR-10-0398","article-title":"Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells","volume":"8","author":"Li","year":"2010","journal-title":"Mol Cancer Res"},{"issue":"4","key":"10.1016\/j.ygyno.2013.06.031_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1677\/ERC-10-0107","article-title":"The chemokine CXCL 1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor","volume":"17","author":"Bolitho","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ygyno.2013.06.031_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story: bench to bedside and back","volume":"22","author":"St","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"51","key":"10.1016\/j.ygyno.2013.06.031_bb0060","doi-asserted-by":"crossref","first-page":"40201","DOI":"10.1074\/jbc.M110.147330","article-title":"Abl kinases are required invadopodia formation and chemokine-induced invasion","volume":"285","author":"Smith-Pearson","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.ygyno.2013.06.031_bb0065","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1158\/0008-5472.CAN-06-0734","article-title":"Activation of Abl tyrosine kinase promotes invasion of aggressive breast cancer cells","volume":"66","author":"Srinivasan","year":"2006","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ygyno.2013.06.031_bb0070","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/sj.onc.1210714","article-title":"Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival","volume":"27","author":"Srinivasan","year":"2008","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.ygyno.2013.06.031_bb0075","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/onc.2011.361","article-title":"c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression","volume":"31","author":"Ganguly","year":"2012","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.031_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/0008-5472.CAN-12-3151","article-title":"ABL regulation by AXL promotes cisplatin resistance in esophageal cancer","volume":"73","author":"Hong","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.031_bb0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2012.06.008","article-title":"High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer","volume":"127","author":"Zhang","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.06.031_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jb\/mvg146","article-title":"Regulation of actin dynamics by WASP family protein","volume":"134","author":"Miki","year":"2003","journal-title":"J Biochem"},{"issue":"10","key":"10.1016\/j.ygyno.2013.06.031_bb0095","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/bi901721u","article-title":"Regulation of actin polymerization and adhesion-dependent cell edge protrusion by the Abl-related gene (Arg) tyrosine kinase and N-W-ASp","volume":"49","author":"Miller","year":"2010","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.031_bb0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tins.2009.09.003","article-title":"Molecular layers underlying cytoskeletal remodeling during cortical development","volume":"33","author":"Heng","year":"2010","journal-title":"Trends Neurosci"},{"issue":"19","key":"10.1016\/j.ygyno.2013.06.031_bb0105","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1242\/jcs.039859","article-title":"Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts","volume":"122","author":"Bradley","year":"2009","journal-title":"J Cell Sci"},{"issue":"17","key":"10.1016\/j.ygyno.2013.06.031_bb0110","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1093\/emboj\/19.17.4589","article-title":"Scar\/WAVE-1, a Wiskott\u2013Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold","volume":"19","author":"Westphal","year":"2000","journal-title":"EMBO J"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.031_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2009.02.025","article-title":"Tyrosine kinase B receptor and BDNF expression ovarian cancers-effect on cell migration, angiogenesis and clinical outcome","volume":"281","author":"Au","year":"2009","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.ygyno.2013.06.031_bb0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ygyno.2011.11.018","article-title":"Targeted inhibition of telomerase activity combined with chemotherapy demonstrates synergy in eliminating ovarian cancer spheroid-forming cells","volume":"124","author":"Erhong","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.06.031_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1242\/jcs.008037","article-title":"Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation","volume":"1-21","author":"Ayala","year":"2008","journal-title":"J Cell Sci"},{"issue":"2","key":"10.1016\/j.ygyno.2013.06.031_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ceb.2008.01.005","article-title":"Assembly and biological role of podosomes and invadopodia","volume":"20","author":"Gimona","year":"2008","journal-title":"Curr Opin Cell Biol"},{"issue":"15","key":"10.1016\/j.ygyno.2013.06.031_bb0135","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/onc.2010.562","article-title":"Liprin-\u03b1 1 regulates breast cancer cell invasion by affecting cell motility, invadopodia and extracellular matrix degradation","volume":"30","author":"Astro","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2013.06.031_bb0140","first-page":"51","article-title":"The family kinases: mechanisms of regulation and signaling","volume":"8-5","author":"Ann Marie","year":"2002","journal-title":"Adv Cancer Res"},{"issue":"4","key":"10.1016\/j.ygyno.2013.06.031_bb0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1677\/erc.1.00801","article-title":"Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors","volume":"11","author":"Singer","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"49","key":"10.1016\/j.ygyno.2013.06.031_bb0150","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1038\/sj.onc.1210500","article-title":"Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product FUS1","volume":"26","author":"Lin","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ygyno.2013.06.031_bb0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.onc.1208996","article-title":"Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase","volume":"25","author":"Nagano","year":"2006","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.ygyno.2013.06.031_bb0160","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1002\/cncr.25420","article-title":"The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors","volume":"116","author":"Koos","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2013.06.031_bb0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2005.09.041","article-title":"Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers","volume":"101","author":"Coleman","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813008640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813008640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T15:14:35Z","timestamp":1563290075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813008640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0090825813008640"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.031","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}